Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
Date:8/8/2011

re to evaluate the safety, tolerability and efficacy of three dose levels of AVP-923 capsules for the treatment of central neuropathic pain in a population of patients with multiple sclerosis.
  • In August, the company announced the appointment of Dr. Joao Siffert as senior vice president research & development.

  • Cash, Cash Equivalents & Marketable SecuritiesAs of June 30, 2011 Avanir had cash, cash equivalents and investments in securities totaling $93.5 million, including cash and cash equivalents of $91.3 million and restricted investments in securities of $2.2 million.

    Note to Investors: As previously announced, Avanir will hold a conference call to discuss fiscal 2011 third quarter financial results today, August 8, 2011, beginning at 1:30 p.m. Pacific Time. You can listen to this call by dialing 1-877-558-3407 for domestic callers or +1-706-679-1941 for international callers, and entering passcode 87076138. Those interested in listening to the conference call live via the internet may do so by visiting http://www.avanir.com.

    About NUEDEXTANUEDEXTA® is the first and only FDA-approved treatment for pseudobulbar affect (PBA). NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling therapeutic dextromethorphan concentrations. NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.

    NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurological conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the pati
    '/>"/>

    SOURCE Avanir Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
    2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
    3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
    4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
    5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
    6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
    7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
    8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
    9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
    10. Avanir Pharmaceuticals to Present at Three Conferences in March
    11. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)... July 30, 2014   Medical Equipment Solutions, Corp. ... awarded a Department of Defense (US Army) contract valued ... a mobile MRI diagnostic machine and technical support staffing. ... through the Small Business Administration (SBA), Medical Equipment is ... with the latest medical diagnostic equipment. The SBA 8-A ...
    (Date:7/30/2014)... , July 30, 2014   Epic Sciences, ... that designs and develops novel diagnostics to personalize ... announced today the completion of a $30 million ... new investors RusnanoMedInvest (RMI) and Arcus Ventures, existing ... Venture Investments, as well as undisclosed individual investors. ...
    (Date:7/30/2014)... July 30, 2014 Company ... programming expertise to big data, aerospace and defense, ... eInfochips, a leading engineering R&D services company, today ... NVIDIA GPU-powered solutions for aerospace and defense ... (HPC), industrial , and visual ...
    Breaking Medicine Technology:Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3eInfochips to Develop NVIDIA GPU-powered Solutions for Aerospace and Defense, Medical Imaging, HPC and Visual Computing 2
    ... , , SOLON, Ohio, Dec. 16 ... of next generation technologies and a principal subcontractor for ... led development of new anthropromorphic arm technology that will ... and hand, including a sense of touch. , ...
    ... 16 A new application developed by American ... pharmaceuticals has increased health plan staff productivity and the number ... diagnostic imaging benefit management and technology company with health plan ... of WellPoint, Inc. (NYSE: WLP ), adapted the ...
    Cached Medicine Technology:HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4
    (Date:7/30/2014)... July 30, 2014 Everyone knows that the ... basically everyone. Whether people are looking for something to buy, ... a dentist, the internet is pretty much always going to ... Dental in Lauderdale Florida is so happy to announce the ... web presence into the modern age. Whether a person wants ...
    (Date:7/30/2014)... (PRWEB) July 30, 2014 With the recent ... Ground Zero, the Ground Zero Museum Workshop in the Meatpacking ... bookings. Says the Museum Workshop's Carole Barnes, "We have had ... all the major travel sites who sell us so tourists ... crystal clear as to what we do and what the ...
    (Date:7/30/2014)... Decene is an alkene with the formula C10H20. ... with one double bond. 1-Decene enters all reactions ... used as a co-monomer in certain copolymers and ... alcohols, synthetic lubricants, synthetic fatty acids, and alkylated ... customization on this report. , http://www.micromarketmonitor.com/contact/2523613387-request_for_customization.html ...
    (Date:7/30/2014)... July 30, 2014 The Europe Phytochemicals ... Phytochemicals & plant extracts market in Europe with analysis ... market in Europe is estimated to grow from around ... at a CAGR of 8.4%, for the given period. ... & plant extracts market report, to get an idea ...
    (Date:7/30/2014)... diagnosed with depression as preschoolers are likely to suffer ... research shows. , Depressed preschoolers were 2.5 times more ... middle school than kids who were not depressed at ... School of Medicine in St. Louis. , Their study ... American Journal of Psychiatry . , "It,s the same ...
    Breaking Medicine News(10 mins):Health News:Sierra Dental Releases New Website For Fort Lauderdale Residents 2Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 2Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 3Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 4Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 5Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Many depressed preschoolers still suffer in later school years 2Health News:Many depressed preschoolers still suffer in later school years 3
    ... May 29 Conseco, Inc. (NYSE:,CNO) today announced ... made by,Steel Partners II, L.P. to increase its ... of the response letter sent to Steel Partners ... Conseco, Inc.,s insurance companies help protect working American,families ...
    ... TEL AVIV, Israel, May 29 Elbit Imaging Ltd.,(Nasdaq: ... its results for the,first quarter of 2008., Loss ... 3.5 million,(approximately US$ 1.0 million) of which loss of ... the equity holders of,the Company, while profit of NIS ...
    ... ROCHELLE, N.Y., May 29 Subjects with type ... glucose levels more frequently and,use the results to ... to a collection of state-of-the-art reports that,comprise a ... 10, Supplement,1) of Diabetes Technology & Therapeutics, a ...
    ... New research from the Oregon Health & Science ... a wellspring of hope to many patients. , Researchers ... DNA abnormalities that can occur in a gene called ... kinds of acral and mucosal melanomas, which are less ...
    ... discovered by Tel Aviv University researcher Prof. Illana Gozes ... Alzheimer,s disease. This compound could also treat a number ... as schizophrenia and Parkinson,s, by limiting damage to the ... was found to protect American patients with mild cognitive ...
    ... bacteria break their metabolic processes into chunks. That may ... have now figured out the factors that tend to ... Santa Fe Institute and Stanford University, together with Anat ... University, constructed the metabolic networks of many species of ...
    Cached Medicine News:Health News:Conseco Declines Proposal from Steel Partners II, L.P.; Proposal Would Reduce Conseco's Financial Flexibility and Potentially Disadvantage Other Shareholders 2Health News:Conseco Declines Proposal from Steel Partners II, L.P.; Proposal Would Reduce Conseco's Financial Flexibility and Potentially Disadvantage Other Shareholders 3Health News:Conseco Declines Proposal from Steel Partners II, L.P.; Proposal Would Reduce Conseco's Financial Flexibility and Potentially Disadvantage Other Shareholders 4Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 2Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 3Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 4Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 5Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 6Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 7Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 8Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 9Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 10Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 11Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 12Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 13Health News:Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics 2Health News:Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics 3Health News:OHSU Cancer Instutute researchers find abnormalities in gene for melanoma 2Health News:Appealing the death sentence for brain cells 2
    8 mm diameter curved probes with suture eyes just back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.6 inches....
    The Novus 2000 argon laser combines power, size, and versatility. Ideal for the office, clinic and operating room environments, Novus 2000 is the world's most widely accepted ophthalmic laser....
    The Meridian Microruptor V Nd: YAG laser system is indicated for posterior capsulotomy, peripheral iridotomy, and pupillary membranectomy procedures....
    Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with thumb catch lock and dull finish....
    Medicine Products: